Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden
· Delayed Price · Currency is SEK 5.33
-0.05 (-0.93%)
Jul 8, 2025, 1:28 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 261.12 million as of July 8, 2025. Its market cap has increased by 470.17% in one year.
Market Cap
261.12M
Enterprise Value
215.47M
Revenue
4.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.33
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 261.12M, an increase of 112.90%. That is a compound annual growth rate of 20.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 264.52M | 351.35% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 98.92B |
| Sectra AB | 67.83B |
| Getinge AB | 52.49B |
| Asker Healthcare Group AB | 39.84B |
| Medicover AB | 39.48B |
| Camurus AB | 38.36B |
| AddLife AB | 22.81B |
| Vimian Group AB | 22.01B |